Ci sarà una su larga scala “infezione secondaria”?

Recentemente, Maria Van Kokhoff, direttore tecnico del progetto emergenza sanitaria dell’OMS, detto che attualmente ce ne sono più di 80,000 nuove sequenze genetiche del coronavirus nel mondo, e la maggior parte delle mutazioni non influenzerà l’infettività e la gravità del virus. The WHO has established a special working group to confirm different mutations and study their possible impact on virus behavior.

Tuttavia, the genetic sequence of the two infections of the patient discovered this time is obviously different. Does the emergence of this case mean that the future virus mutation will bring a large-scale “second infection” risk?

“Small virus mutations will not have a big impact on the epidemic situation, and dozens of amino acid mutations will not have much impact on the structure of the entire virus.” Wu Zunyou said.

He emphasized that this case in Hong Kong is a case, but there is also an important reminder: After recovering from the new coronary pneumonia patients, they can still be infected with the new coronavirus, and there may be patients with similar conditions.

Shenzhen Medico manufacturer warmly reminds that the best way to prevent a pandemic is to isolate and prevent human-to-human transmission, and with the launch of vaccines and mass vaccination, this risk will become smaller and smaller.